Matrix metalloprotease inhibitors

MYPI1996005261A0Inactive Publication Date: 1997-06-20F HOFFMANN LA ROCHE & CO AG +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI1996005261
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
1996-12-04
Filing Date
1996-12-13
Publication Date
1997-06-20
Estimated Expiration
Not applicable · inactive patent
Patent Text Reader

Abstract

COMPOUNDS OF THE FORMULA: WHEREIN: N IS 0, 1 OR 2; Y IS HYDROXY OR XONH-, WHERE X IS HYDROGEN OR LOWER ALKYL; R1 IS HYDROGEN OR LOWER ALKYL; R2 IS HYDROGEN, LOWER ALKYL, HETEROALKYL, ARYL, ARALKYL, ARYLHETEROALKYL, CYCLOALKYL, CYCLOALKYLALKYL, HETEROARYL, HETEROARALKYL, HETEROARYLHETEROALKYL, HETEROCYCLO, HETEROCYLO-LOWER ALKYL, HETEROCYCLO-LOWER HETEROALKYL OR -NR6R7, WHEREIN: R6 IS HYDROGEN, LOWER ALKYL, CYCLOALKYL OR CYCLOALKYLALKYL, ARYL, HETEROARYL AND HETEROARALKYL; R7 IS HYDROGEN, LOWER ALKYL, CYCLOALKYL OR CYCLOALKYLALKYL, ARYL, ARALKYL, HETEROARYL, HETEROARALKYL, -C(O)R8, -C(O)NR8R9, -SO2NR8R9, -SO2R10, ARYLOXYCARBONYL, OR ALKOXYCARBONYL; OR R6 AND R7 TOGETHER WITH THE NITROGEN ATOM TO WHICH THEY ARE ATTACHED REPRESENT A HETEROCYCLO GROUP; WHEREIN R8 AND R9 ARE INDEPENDENTLY HYDROGEN, LOWER ALKYL, CYCLOALKYL, CYCLOALKYLALKYL, ARYL, ARALKYL, HETEROARYL, HETEROARALKYL OR HETEROALKYL; AND R10 IS LOWER ALKYL, CYCLOALKYL, CYCLOALKYLALKYL, ARYL, ARALKYL, HETEROARYL, HETEROARALKYL, HETEROALKYL OR HETEROCYCLO; OR R1 AND R2 TOGETHER WITH THE CARBON ATOM TO WHICH THEY ARE ATTACHED REPRESENT A CYCLOALKYL OR HETEROCYCLO GROUP; R3 IS HYDROGEN, LOWER ALKYL, CYCLOALKYL, CYCLOALKYLALKYL, ARYL, ARALKYL, HETEROARY1, HETEROARALKY1, HETEROALKY1 OR LOWER ALKOXY; R4 IS HYDROGEN, LOWER ALKYL, CYCLOALKYL OR CYCLOALKYLA1KY1; OR R2 AND R3 TOGETHER WITH THE CARBONS TO WHICH THEY ARE ATTACHED REPRESENT A CYCLOALKYL OR HETEROCYCLO GROUP; OR R3 AND R4 TOGETHER WITH THE CARBON TO WHICH THEY ARE ATTACHED REPRESENT A CYCLOA1KY1 OR HETEROCYCLO GROUP; AND R5 IS 1OWER ALKYL, CYCLOA1KY1, CYCLOALKYLALKY1, ARYL, ARALKYL, HETEROARYL, OR HETEROARALKYL; OR PHARMACEUTICA1LY ACCEPTABLE SALTS OR ESTERS THEREOF EXHIBIT USEFUL PHARMACOLOGICAL PROPERTIES, IN PARTICULAR FOR USE AS MATRIX METALLOPROTEASE INHIBITORS, PARTICULARLY FOR INTERSTITIAL COLLAGENASES.
Need to check novelty before this filing date? Find Prior Art